Literature DB >> 20237089

Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation.

Rachel McCloskey1, Craig Menges, Alan Friedman, Daksha Patel, Dennis J McCance.   

Abstract

The E6 and E7 oncoproteins of high-risk human papillomaviruses (HPVs) are together sufficient to cause cellular transformation. Nucleophosmin (NPM) was identified as a protein with increased levels in two-dimensional (2-D) gel analysis of human foreskin keratinocytes (HFKs) expressing E7 following methylcellulose-induced differentiation. Analysis of NPM expression in E7-expressing cells and E6- and E7-expressing cells in culture and in organotypic rafts confirmed the increased levels observed in 2-D gel analysis. The elevated expression of NPM was determined to be posttranscriptional and was attributed to increased v-akt murine thymoma viral oncogene (AKT) activity in the E6- and E7-expressing cells. Depletion of NPM caused a reduction in the replicative capacity of E7- and E6/E7-expressing HFKs and an increase in markers of differentiation. Also, the p53 and pRb tumor suppressor levels are increased with the knockdown of NPM in E6/E7-expressing cells, and, interestingly, p14(ARF) is relocalized from the nucleolus to the nucleoplasm and cytoplasm in these cells. The results show for the first time that NPM is required for the proliferation and inhibition of differentiation observed in HPV E6- and E7-expressing primary cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237089      PMCID: PMC2863842          DOI: 10.1128/JVI.01965-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Nucleophosmin and cancer.

Authors:  Silvia Grisendi; Cristina Mecucci; Brunangelo Falini; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 2.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.

Authors:  K Münger; J R Basile; S Duensing; A Eichten; S L Gonzalez; M Grace; V L Zacny
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

3.  Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.

Authors:  Scott Balsitis; Fred Dick; Nicholas Dyson; Paul F Lambert
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

Review 4.  Cell cycle control and beyond: emerging roles for the retinoblastoma gene family.

Authors:  C Genovese; D Trani; M Caputi; P P Claudio
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

5.  Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.

Authors:  C Y Hsu; B Y Yung
Journal:  Int J Cancer       Date:  2000-11-01       Impact factor: 7.396

6.  NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.

Authors:  W Qi; K Shakalya; A Stejskal; A Goldman; S Beeck; L Cooke; D Mahadevan
Journal:  Oncogene       Date:  2008-03-17       Impact factor: 9.867

7.  Role of Npm1 in proliferation, apoptosis and differentiation of neural stem cells.

Authors:  Yang Qing; Gao Yingmao; Bing Lujun; Li Shaoling
Journal:  J Neurol Sci       Date:  2007-10-18       Impact factor: 3.181

8.  Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival.

Authors:  Sang Bae Lee; Truong L Xuan Nguyen; Joung Woo Choi; Kyung-Hoon Lee; Sung-Woo Cho; Zhixue Liu; Keqiang Ye; Sun Sik Bae; Jee-Yin Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

9.  ARF in the mitochondria: the last frontier?

Authors:  Koji Itahana; Hilary V Clegg; Yanping Zhang
Journal:  Cell Cycle       Date:  2008-12-16       Impact factor: 4.534

10.  Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival.

Authors:  Xia Liu; Zhixue Liu; Sung-Wuk Jang; Zhiyong Ma; Kazuya Shinmura; Sumin Kang; Shaozhong Dong; Jing Chen; Kenji Fukasawa; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

View more
  15 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.

Authors:  Paula L Hyland; Simon S McDade; Rachel McCloskey; Glenda J Dickson; Ken Arthur; Dennis J McCance; Daksha Patel
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 3.  Crosstalk between the nucleolus and the DNA damage response.

Authors:  L M Ogawa; S J Baserga
Journal:  Mol Biosyst       Date:  2017-02-28

4.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

5.  Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.

Authors:  Xicheng Song; Erich M Sturgis; Zhigang Huang; Xiaodong Li; Chao Li; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2013-10-08       Impact factor: 4.944

Review 6.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

7.  The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation.

Authors:  Ling-juan Gao; Ping-qing Gu; Wei Zhao; Wen-yan Ding; Xue-qing Zhao; Shu-yu Guo; Tian-ying Zhong
Journal:  J Transl Med       Date:  2013-05-08       Impact factor: 5.531

8.  Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes.

Authors:  Eszter Gyöngyösi; Anita Szalmás; Annamária Ferenczi; József Kónya; Lajos Gergely; György Veress
Journal:  Virol J       Date:  2012-02-14       Impact factor: 4.099

9.  The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species.

Authors:  Jennifer M Spangle; Karl Munger
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

10.  The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Authors:  Uzma A Hasan; Claudia Zannetti; Peggy Parroche; Nadège Goutagny; Marine Malfroy; Guillaume Roblot; Christine Carreira; Ishraq Hussain; Martin Müller; Joyce Taylor-Papadimitriou; Didier Picard; Bakary S Sylla; Giorgio Trinchieri; Ruslan Medzhitov; Massimo Tommasino
Journal:  J Exp Med       Date:  2013-06-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.